David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$528M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$447M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$242M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$233M |
| 5 |
Meta Platforms (Facebook)
META
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$751M |
| 2 |
Pfizer
PFE
|
+$320M |
| 3 |
BMC
BMC SOFTWARE, INC
BMC
|
+$264M |
| 4 |
Visa
V
|
+$201M |
| 5 |
McDonald's
MCD
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.42% |
| 2 | Consumer Discretionary | 7% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.82% |
| 5 | Communication Services | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
PUT
Annaly Capital Management
NLY
$17.4B
| $6.07M | 0.01% |
131,075
+89,500
| +215% | +$4.21M |
|
1402
PUT
UnitedHealth
UNH
$356B
| $6.04M | 0.01% |
84,400
+69,600
| +470% | +$4.98M |
|
1403
PUT
Humana
HUM
$46.8B
| $6.03M | 0.01% |
64,600
+4,600
| +8% | +$422K |
|
1404
Honda
HMC
$41.3B
| $6.03M | 0.01% |
158,014
+101,380
| +179% | +$3.87M |
|
|
GXP
1405
DELISTED
Great Plains Energy Incorporated
GXP
| $6.03M | 0.01% |
271,454
+214,109
| +373% | +$4.93M |
|
1406
Adtran
ADTN
$653M
| $6.02M | 0.01% |
226,057
+41,080
| +22% | +$1.07M |
|
1407
PUT
Factset
FDS
$10.5B
| $6.02M | 0.01% |
+55,200
| New | +$5.96M |
|
|
FCS
1408
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $6.02M | 0.01% |
433,496
+63,685
| +17% | +$835K |
|
|
INFI
1409
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $6.02M | 0.01% |
344,969
-287,784
| -45% | -$5.51M |
|
1410
PUT
Designer Brands
DBI
$280M
| $6.01M | 0.01% |
141,000
+80,000
| +131% | +$3.23M |
|
1411
Hershey
HSY
$37.6B
| $6.01M | 0.01% |
64,986
+21,187
| +48% | +$1.98M |
|
1412
Stanley Black & Decker
SWK
$14.9B
| $6.01M | 0.01% |
66,358
-106,872
| -62% | -$9.16M |
|
|
WFM
1413
DELISTED
Whole Foods Market Inc
WFM
| $6.01M | 0.01% |
102,731
-7,902
| -7% | -$436K |
|
1414
CALL
Abercrombie & Fitch
ANF
$4.84B
| $6.01M | 0.01% |
169,900
+102,400
| +152% | +$4.53M |
|
1415
H.B. Fuller
FUL
$3.07B
| $6.01M | 0.01% |
132,947
+79,385
| +148% | +$3.17M |
|
1416
Arthur J. Gallagher & Co
AJG
$68.8B
| $6M | 0.01% |
+137,443
| New | +$6.03M |
|
1417
CALL
Universal Health Services
UHS
$10.4B
| $6M | 0.01% |
80,000
| – | – |
|
1418
PUT
Cullen/Frost Bankers
CFR
$10.2B
| $6M | 0.01% |
85,000
+78,300
| +1,169% | +$5.57M |
|
1419
PUT
Coca-Cola Europacific Partners
CCEP
$48.5B
| $5.99M | 0.01% |
149,000
+40,600
| +37% | +$1.55M |
|
1420
BioCryst Pharmaceuticals
BCRX
$2.51B
| $5.99M | 0.01% |
822,508
+748,058
| +1,005% | +$3.79M |
|
|
DYAX
1421
DELISTED
DYAX CORPORATION
DYAX
| $5.99M | 0.01% |
872,725
+107,955
| +14% | +$490K |
|
|
BIN
1422
DELISTED
PROGRESSIVE WASTE SOLUTIONS LTD COM
BIN
| $5.97M | 0.01% |
232,097
-162,066
| -41% | -$3.9M |
|
1423
Cencora
COR
$62.6B
| $5.97M | 0.01% |
97,683
-226,555
| -70% | -$13.2M |
|
|
ENOC
1424
DELISTED
EnerNOC, Inc.
ENOC
| $5.96M | 0.01% |
397,770
-121,145
| -23% | -$1.82M |
|
|
ATML
1425
DELISTED
ATMEL CORP
ATML
| $5.96M | 0.01% |
801,228
+690,406
| +623% | +$5.25M |
|
Similar funds
David Shaw's Q3 2013 Portfolio in Review
As of Q3 2013, David Shaw held 4,679 positions worth $62.7B, up 18% from $53.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
David Shaw deployed $4.08B of net new capital in Q3 2013, opening 738 new positions and adding to 1,785 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 14,172,864 shares worth $473M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 9.9% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $751M trimmed.
- David Shaw's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 14,172,864 shares worth $473M.
- David Shaw added most to DELL INC in Q3 2013, an estimated $528M increase.
- David Shaw's biggest Q3 2013 reduction was Apple, cutting an estimated $751M.
- David Shaw fully exited BMC SOFTWARE, INC in Q3 2013, selling an estimated $264M.
- David Shaw's ten largest holdings make up 14% of its $62.7B portfolio in Q3 2013.
- David Shaw opened 738 new positions and closed 426 in Q3 2013.
- David Shaw's portfolio value rose 18% quarter-over-quarter to $62.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2013, filed 14 Nov 2013.